HRP20161320T1 - Kimerni polipeptidi i njihova upotreba u dekoloniziranju bakterija - Google Patents

Kimerni polipeptidi i njihova upotreba u dekoloniziranju bakterija

Info

Publication number
HRP20161320T1
HRP20161320T1 HRP20161320TT HRP20161320T HRP20161320T1 HR P20161320 T1 HRP20161320 T1 HR P20161320T1 HR P20161320T T HRP20161320T T HR P20161320TT HR P20161320 T HRP20161320 T HR P20161320T HR P20161320 T1 HRP20161320 T1 HR P20161320T1
Authority
HR
Croatia
Prior art keywords
chimeric polypeptides
decolonization
bacterial
bacterial decolonization
chimeric
Prior art date
Application number
HRP20161320TT
Other languages
English (en)
Inventor
Holger Grallert
Sonja Leopoldseder
Original Assignee
Hypharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42153758&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20161320(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hypharm Gmbh filed Critical Hypharm Gmbh
Publication of HRP20161320T1 publication Critical patent/HRP20161320T1/hr
Publication of HRP20161320T4 publication Critical patent/HRP20161320T4/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886Metalloendopeptidases (3.4.24), e.g. collagenase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462Lysozyme (3.2.1.17)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/33Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24Metalloendopeptidases (3.4.24)
    • C12Y304/24075Lysostaphin (3.4.24.75)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HRP20161320TT 2009-12-23 2016-10-11 Kimerni polipeptidi i njihova upotreba u dekoloniziranju bakterija HRP20161320T4 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09015998A EP2338916A1 (en) 2009-12-23 2009-12-23 Chimeric polypeptides and their use in bacterial decoloniation
PCT/EP2010/007941 WO2011076432A1 (en) 2009-12-23 2010-12-23 Chimeric polypeptides and their use in bacterial decolonization
EP10798274.6A EP2516471B9 (en) 2009-12-23 2010-12-23 Chimeric polypeptides and their use in bacterial decolonization

Publications (2)

Publication Number Publication Date
HRP20161320T1 true HRP20161320T1 (hr) 2016-12-16
HRP20161320T4 HRP20161320T4 (hr) 2020-07-10

Family

ID=42153758

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20161320TT HRP20161320T4 (hr) 2009-12-23 2016-10-11 Kimerni polipeptidi i njihova upotreba u dekoloniziranju bakterija

Country Status (14)

Country Link
US (4) US9057059B2 (hr)
EP (2) EP2338916A1 (hr)
CY (1) CY1118331T1 (hr)
DK (1) DK2516471T4 (hr)
ES (1) ES2597579T5 (hr)
HR (1) HRP20161320T4 (hr)
HU (1) HUE031164T2 (hr)
LT (1) LT2516471T (hr)
PL (1) PL2516471T5 (hr)
PT (1) PT2516471T (hr)
RS (1) RS55230B1 (hr)
SI (1) SI2516471T2 (hr)
SM (1) SMT201600365B (hr)
WO (1) WO2011076432A1 (hr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9200251B1 (en) 2011-03-31 2015-12-01 David Gordon Bermudes Bacterial methionine analogue and methionine synthesis inhibitor anticancer, antiinfective and coronary heart disease protective microcins and methods of treatment therewith
CN111803620A (zh) * 2012-05-09 2020-10-23 康特拉费克特公司 使用噬菌体溶素的生物膜预防、破坏和处理
US20150284452A1 (en) * 2012-11-13 2015-10-08 Iogenetics, Llc Antimicrobial compositions
CN103122347B (zh) * 2013-02-01 2015-04-22 中国科学院武汉病毒研究所 一种杀灭葡萄球菌的裂解酶及其应用
EP3019185B1 (en) * 2013-07-11 2020-11-18 Micreos Human Health B.V. Combination treatment for atopic dermatitis
EP2904912A1 (en) 2014-02-07 2015-08-12 Hyglos Invest GmbH Novel high pressure method with endolysin for processing of foods
CN107580503B (zh) * 2015-03-12 2021-07-09 迈克瑞欧斯人体健康有限公司 用于治疗细菌感染的杀菌剂与亲溶酶体碱化剂的组合
CN104805066B (zh) * 2015-05-18 2018-04-24 武汉菲吉乐科生物科技有限公司 一种葡萄球菌裂解酶及其应用
EP3541406B1 (en) * 2016-11-18 2022-03-16 Lysando AG New antimicrobial agents against staphylococcus aureus
US10256592B1 (en) * 2017-04-27 2019-04-09 Lockheed Martin Corporation Device, system and method with cascaded burst mode laser amplified pumping oscillator signal
US20220024992A1 (en) * 2018-11-02 2022-01-27 The Rockefeller University Compositions and methods comprising lysocins as bioengineered antimicrobials for use in targeting gram-negative bacteria
EP3969578A1 (en) * 2019-05-08 2022-03-23 BioNTech R&D (Austria) GmbH Novel gardnerella endolysins and uses thereof
GB201906653D0 (en) * 2019-05-10 2019-06-26 Cc Biotech Ltd Polypeptides for treatment of bacterial infections
EP3771463A1 (en) 2019-07-29 2021-02-03 Ludwig-Maximilians-Universität München Stabilizing therapeutic proteins with piperazin- or morpholine-containing zwitterionic buffering substances
AU2021238683A1 (en) 2020-03-19 2022-10-13 Micreos Human Health B.V. A stabilized protein of interest

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2255561B (en) 1991-04-20 1995-06-21 Agricultural & Food Res Lysins from bacteriophages
US5997862A (en) 1997-10-31 1999-12-07 New Horizons Diagnostics Corporation Therapeutic treatment of group A streptococcal infections
US7572602B1 (en) * 2004-12-03 2009-08-11 The United States Of America As Represented By The Secretary Of Agriculture Nucleic acid encoding endolysin fusion protein
CA2651125C (en) 2006-05-05 2016-06-28 Gangagen, Inc. Phage derived antimicrobial activities
IE20060488A1 (en) 2006-06-29 2008-01-09 Teagasc Agric Food Dev Authori Recombinant staphylococcal phage lysin as an antibacterial agent
US20090130082A1 (en) * 2007-10-18 2009-05-21 Kaplan Jeffrey B Compositions and methods for the treatment and prevention of infections caused by staphylococcus aureus bacteria
US8481289B2 (en) * 2008-07-24 2013-07-09 The United States Of America, As Represented By The Secretary Of Agriculture Triple acting antimicrobials that are refractory to resistance development
US8383102B2 (en) * 2009-05-21 2013-02-26 The United States Of America As Represented By The Secretary Of Agriculture Fusion of peptidoglycan hydrolase enzymes to a protein transduction domain allows eradication of both extracellular and intracellular gram positive pathogens

Also Published As

Publication number Publication date
EP2516471B1 (en) 2016-07-13
US11116824B2 (en) 2021-09-14
LT2516471T (lt) 2016-10-25
PL2516471T3 (pl) 2017-01-31
EP2516471B9 (en) 2020-10-28
EP2516471A1 (en) 2012-10-31
US10342857B2 (en) 2019-07-09
US20190381151A1 (en) 2019-12-19
US20180333471A1 (en) 2018-11-22
CY1118331T1 (el) 2017-06-28
SI2516471T1 (sl) 2016-11-30
US20130004476A1 (en) 2013-01-03
US10022430B2 (en) 2018-07-17
PL2516471T5 (pl) 2020-10-19
PT2516471T (pt) 2016-10-20
ES2597579T3 (es) 2017-01-19
DK2516471T4 (da) 2020-08-03
US20150238577A1 (en) 2015-08-27
ES2597579T5 (es) 2021-03-18
SI2516471T2 (sl) 2020-07-31
WO2011076432A1 (en) 2011-06-30
HUE031164T2 (en) 2017-06-28
EP2516471B2 (en) 2020-05-27
HRP20161320T4 (hr) 2020-07-10
DK2516471T3 (en) 2016-10-17
EP2338916A1 (en) 2011-06-29
SMT201600365B (it) 2016-11-10
RS55230B1 (sr) 2017-02-28
US9057059B2 (en) 2015-06-16

Similar Documents

Publication Publication Date Title
HRP20161320T1 (hr) Kimerni polipeptidi i njihova upotreba u dekoloniziranju bakterija
IL261851B (en) Reprogramming of t cells and hematopoietic cells
HRP20181493T1 (hr) Konjugati epsilon-polilizin i njihova primjena
PL2529016T3 (pl) Sposoby i kompozycje stosujące polipeptydy fuzyjne fgf23
ZA201204697B (en) Chimeric endonucleases and uses thereof
SI2569009T1 (sl) Himere OSPA in njihova uporaba v cepivih
GB0916578D0 (en) Polypeptides and uses thereof
EP2504429A4 (en) CHIMERIC ENDONUCLEASES AND USES THEREOF
EP2383283A4 (en) NOGGIN PEPTIDE AND ITS USE
EP2483292A4 (en) LOVD VARIANT POLYPEPTIDES AND USES THEREOF
GB0916576D0 (en) Polypeptides and uses thereof
EP2474555A4 (en) PEPTIDE DERIVED FROM WNT10 AND USE THEREOF
EP2402429A4 (en) EQUOL-PRODUCING BACTERIUM AND ITS USE
EP2622524A4 (en) SIMPLIFICATION OF REST RELATIONS IN A PROTEIN DESIGN
EP2478014A4 (en) FUSION POLYPEPTIDES AND USES THEREOF
EP2436756A4 (en) BACTERIA OBTAINING TO SELECTIVE BROKEN TISSUE AND USE THEREOF
GB0902429D0 (en) Compositions and their use
HK1168363A1 (en) Novel peptide and use thereof
IL199618A0 (en) Novel antibodies and their use in diagnostic methods
GB0917533D0 (en) Azaphthalocyanines and their use in printing
EP2410017A4 (en) COMPOSITION AND ELEMENT USING THE SAME
GB0905970D0 (en) Depsipeptides and their therapeutic use
GB0905790D0 (en) Novel polypeptides and use thereof
EP2450374A4 (en) PEPTIDE AND ITS USE
GB0902812D0 (en) Composition and use